◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Parvis Invest Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 715,943 493,838 348,435 210,186 246,508 --
Operating Revenue 715,943 493,838 348,435 210,186 246,508 --
Selling General And Administration 586,860 640,332 752,616 707,612 614,385 --
General And Administrative Expense 586,860 640,332 752,616 707,612 614,385 --
Operating Expense 586,860 640,332 752,616 707,612 614,385 --
Operating Income 129,083 -146,494 -404,181 -497,426 -367,877 --
EBIT 129,519 -146,062 -403,934 -496,413 -367,304 --
Interest Expense 0.00 1,591 0.00 0.00 42.00 --
Interest Expense Non Operating 0.00 1,591 0.00 0.00 42.00 --
Interest Income 436.00 432.00 247.00 1,013 573.00 --
Interest Income Non Operating 436.00 432.00 247.00 1,013 573.00 --
Net Interest Income 436.00 -1,159 247.00 1,013 531.00 --
Pretax Income 129,519 -147,653 -403,934 -496,413 -367,346 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation 129,520 -147,653 -403,934 -496,413 -367,346 --
Net Income From Continuing Operation Net Minority Interest 129,520 -147,653 -403,934 -496,413 -367,346 --
Net Income Including Noncontrolling Interests 129,519 -147,653 -403,934 -496,413 -367,346 --
Net Income Common Stockholders 129,520 -147,653 -403,934 -496,413 -367,346 --
Net Income 129,520 -147,653 -403,934 -496,413 -367,346 --
EBITDA 131,562 -145,443 -403,314 -495,803 -367,003 --
Normalized EBITDA 131,562 -145,443 -403,314 -495,803 -367,003 --
Reconciled Depreciation 2,043 619.00 620.00 610.00 301.00 --
Basic EPS -- -0.01 -- -0.02 -0.01 -0.01
Diluted EPS -- -0.01 -- -0.02 -0.01 -0.01
Basic Average Shares -- 26.8M -- 26.8M 26.8M 26.8M
Diluted Average Shares -- 26.8M -- 26.8M 26.8M 26.8M
Tax Rate For Calcs 0.15 0.00 0.00 0.00 0.00 --
Normalized Income 129,520 -147,653 -403,934 -496,413 -367,346 --
Diluted NI Availto Com Stockholders 129,520 -147,653 -403,934 -496,413 -367,346 --
Net Income Continuous Operations 129,519 -147,653 -403,934 -496,413 -367,346 --
Net Non Operating Interest Income Expense 436.00 -1,159 247.00 1,013 531.00 --
Other Gand A 560,339 598,110 681,088 633,384 530,113 --
Salaries And Wages 26,521 42,222 71,528 74,228 84,272 --
Total Expenses 586,860 640,332 752,616 707,612 614,385 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 381,130 497,435 400,855 739,327 1.4M --
Cash Cash Equivalents And Short Term Investments 381,130 497,435 400,855 739,327 1.4M --
Cash Financial 381,130 497,435 400,855 739,327 1.4M --
Accounts Receivable 593,083 252,384 397,789 83,025 104,381 --
Receivables 674,605 362,920 517,433 169,504 180,753 --
Prepaid Assets -- 40,156 64,218 84,338 20,967 34,565
Current Assets 1.1M 900,511 982,506 993,169 1.6M --
Net PPE 5,904 3,673 4,293 4,912 3,068 --
Total Non Current Assets 5,904 3,673 4,293 4,912 3,068 --
Total Assets 1.1M 904,184 986,799 998,081 1.6M --
Accounts Payable 102,333 231,169 507,081 39,446 166,466 --
Payables 135,334 231,169 507,081 139,446 266,466 --
Payables And Accrued Expenses 298,998 407,578 650,963 345,307 480,976 --
Current Accrued Expenses 163,664 176,409 143,882 205,861 214,510 --
Current Deferred Revenue 235,947 124,902 160,292 144,824 197,015 --
Other Current Liabilities -1.00 -- -- -- -- --
Current Liabilities 534,944 532,480 811,255 490,131 677,991 --
Long Term Debt 241,355 241,355 -- -- -- --
Long Term Debt And Capital Lease Obligation 241,355 241,355 -- -- -- --
Total Non Current Liabilities Net Minority Interest 241,355 241,355 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 776,299 773,835 811,255 490,131 677,991 --
Common Stock 5.1M 5.1M 5.1M 5.1M 5.1M --
Capital Stock 5.1M 5.1M 5.1M 5.1M 5.1M --
Retained Earnings -6.2M -6.3M -6.2M -5.8M -5.3M --
Common Stock Equity 285,339 130,349 175,544 507,950 930,136 --
Stockholders Equity 285,339 130,349 175,544 507,950 930,136 --
Total Equity Gross Minority Interest 285,339 130,349 175,544 507,950 930,136 --
Total Capitalization 526,694 371,704 175,544 507,950 930,136 --
Net Tangible Assets 285,339 130,349 175,544 507,950 930,136 --
Tangible Book Value 285,339 130,349 175,544 507,950 930,136 --
Working Capital 520,791 368,031 171,251 503,038 927,068 --
Invested Capital 526,694 371,704 175,544 507,950 930,136 --
Total Debt 241,355 241,355 -- -- -- --
Share Issued 26.8M 26.8M 26.8M 26.8M 26.8M --
Ordinary Shares Number 26.8M 26.8M 26.8M 26.8M 26.8M --
Allowance For Doubtful Accounts Receivable 0.00 -- 0.00 0.00 -- --
Current Deferred Liabilities 235,947 124,902 160,292 144,824 197,015 --
Gross Accounts Receivable 593,083 252,384 397,789 83,025 104,381 --
Other Equity Interest 1.4M 1.4M 1.3M 1.2M 1.1M --
Other Payable -- -- -- 100,000 100,000 --
Other Receivables 81,522 110,536 119,644 86,479 76,372 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -116,304 -203,420 -338,471 236,534 -833,523 --
Cash Flow From Continuing Operating Activities -110,982 -203,420 -338,471 236,534 -833,433 --
Depreciation And Amortization 2,043 619.00 620.00 610.00 301.00 --
Depreciation Amortization Depletion 2,043 619.00 620.00 610.00 301.00 --
Stock Based Compensation 26,521 42,222 71,528 53,175 105,325 --
Change In Working Capital -269,066 -100,199 -6,685 309,824 -202,465 --
Change In Receivables -283,475 154,514 -347,930 -82,963 217,747 --
Change In Payables And Accrued Expense -108,580 -243,385 305,656 390,385 -340,523 --
Change In Payable -- -- -- -135,670 -- --
Change In Other Working Capital 111,045 -35,390 15,468 -52,191 24,677 --
Other Non Cash Items -5,322 1,591 -- -- -300,090 90.00
Capital Expenditure -- -- -1.00 -2,434 -- --
Purchase Of PPE -- -- -1.00 -2,434 -- --
Net PPE Purchase And Sale -- -- -1.00 -2,434 -- --
Investing Cash Flow -- -- -1.00 -2,434 -- --
Cash Flow From Continuing Investing Activities -- -- -1.00 -2,434 -- --
Issuance Of Debt 0.00 300,000 -- -- 0.00 0.00
Net Issuance Payments Of Debt 0.00 300,000 -- -- 0.00 0.00
Financing Cash Flow 0.00 300,000 -- -- 0.00 0.00
Cash Flow From Continuing Financing Activities 0.00 300,000 -- -- 0.00 0.00
Changes In Cash -116,305 96,580 -338,472 232,714 -833,523 --
Beginning Cash Position 497,435 400,855 739,327 2.5M 1.3M --
End Cash Position 381,130 497,435 400,855 739,327 2.5M --
Free Cash Flow -116,304 -203,420 -338,472 232,714 -833,523 --
Change In Account Payable -- -- -- -135,670 -- --
Change In Prepaid Assets 11,944 24,062 20,121 -38,454 -11,319 --
Depreciation 2,043 619.00 620.00 610.00 301.00 --
Long Term Debt Issuance 0.00 300,000 -- -- 0.00 0.00
Net Income From Continuing Operations 129,520 -147,653 -403,934 -127,075 -736,594 --
Net Long Term Debt Issuance 0.00 300,000 -- -- 0.00 0.00
NEWS
Loading news...
TRENDING
Loading...